Evidence map›Paper›PMID 39474537›Full record

ArticleCase reports in oncology

Successful Treatment of Unresectable

Saaya Yoshida-Akai, Taku Fujimura, Ryo Amagai, Yumi Kambayashi, Akira Hashimoto, Hitoshi Terui, Kenta Oka, Manami Watanabe-Takahashi, Emi Yamazaki, Kota Ohuchi and 1 more

Abstract readCase Reports
In one paragraph

Article in Case reports in oncology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Saaya Yoshida-AkaiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Taku FujimuraDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Ryo AmagaiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Yumi KambayashiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Akira HashimotoDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Hitoshi TeruiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kenta OkaDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Manami Watanabe-TakahashiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Emi YamazakiDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
Kota OhuchiDepartment of Medical Oncology, Tohoku University Hospital, Sendai, Japan.
Yoshihide AsanoDepartment of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Basal cell carcinoma (BCC) is a common skin cancer that rarely metastasizes but can deeply infiltrate local tissues. The small number of unresectable BCC cases makes it difficult to conduct clinical trials, resulting in delays in the development of effective drugs for BCC. Cancer gene panel testing has led to an increasing number of new treatment proposals for patients with solid tumors for whom no standard treatment is available. Case Presentation: We described a case of unresectable Conclusion: Our present case suggests that comprehensive mutation analysis by gene panel testing is important in advanced BCC because genes other than those involved in the hedgehog signaling pathway can be driver genes.

Indexed as

BRCA1 L63*CisplacinUnresectable basal cell carcinoma

Identifiers

PMID39474537
PMCPMC11521543

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.